Bruker (BRKR) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.66% |
| Dec 31, 2025 | 20.00% |
| Sep 30, 2025 | 24.47% |
| Jun 30, 2025 | 23.27% |
| Mar 31, 2025 | 18.66% |
| Dec 31, 2024 | 16.74% |
| Sep 30, 2024 | 25.03% |
| Jun 30, 2024 | 24.12% |
| Mar 31, 2024 | 14.08% |
| Dec 31, 2023 | 11.71% |
| Sep 30, 2023 | 9.88% |
| Jun 30, 2023 | 9.43% |
| Mar 31, 2023 | 8.32% |
| Dec 31, 2022 | 9.23% |
| Sep 30, 2022 | 12.36% |
| Jun 30, 2022 | 12.94% |
| Mar 31, 2022 | 16.55% |
| Dec 31, 2021 | 19.69% |
| Sep 30, 2021 | 18.30% |
| Jun 30, 2021 | 19.57% |
| Mar 31, 2021 | 18.36% |
| Dec 31, 2020 | 16.10% |
| Sep 30, 2020 | 13.65% |
| Jun 30, 2020 | 15.45% |
| Mar 31, 2020 | 17.20% |
| Dec 31, 2019 | 15.29% |
| Sep 30, 2019 | 9.37% |
| Jun 30, 2019 | 10.95% |
| Mar 31, 2019 | 8.83% |
| Dec 31, 2018 | 7.16% |
| Sep 30, 2018 | 0.83% |
| Jun 30, 2018 | -0.26% |
| Mar 31, 2018 | 1.08% |
| Dec 31, 2017 | 1.47% |
| Sep 30, 2017 | 0.88% |
| Jun 30, 2017 | -1.54% |
| Mar 31, 2017 | -3.19% |
| Dec 31, 2016 | -3.11% |
| Sep 30, 2016 | -2.44% |
| Jun 30, 2016 | -1.53% |
| Mar 31, 2016 | -1.34% |
| Dec 31, 2015 | -2.32% |
| Sep 30, 2015 | 0.79% |
| Jun 30, 2015 | 1.32% |
| Mar 31, 2015 | -0.46% |
| Dec 31, 2014 | 2.92% |
| Sep 30, 2014 | 4.58% |
| Jun 30, 2014 | 5.64% |
| Mar 31, 2014 | 7.68% |
| Dec 31, 2013 | 8.66% |